Revelation Biosciences REVB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q2 | 1.91 | 1 | -158.11 | -8 | -62.21 | 12 |
| 2024Q1 | 2.74 | 9 | -33.26 | -3 | -19.92 | 15 |
| 2023Q4 | 15.02 | 7 | -28.49 | -2 | -16.67 | 12 |
| 2023Q3 | 20.68 | 9 | -25.98 | -3 | -17.37 | 14 |
| 2023Q2 | 28.20 | 11 | -13.51 | -1 | -8.48 | 16 |
| 2023Q1 | 39.00 | 10 | 111.27 | 6 | 52.15 | 18 |
| 2022Q4 | 199.61 | 1 | -73.66 | -1 | -19.96 | 6 |
| 2022Q3 | 274.06 | 2 | -1 | -21.78 | 7 | |
| 2022Q2 | 1165.53 | -2 | -2 | -30.25 | 4 | |
| 2022Q1 | 1197.03 | 0 | -7 | -23.48 | 8 | |
| 2021Q4 | -8 | 6 | 9.83 | 48 | ||
| 2021Q3 | -7 | 4 | 5.66 | 74 | ||
| 2021Q2 | -6 | 2 | 3.32 | 74 | ||
| 2021Q1 | -5 | 1 | 1.59 | 74 | ||
| 2020Q4 | -6 | -2 | 74 |